<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1901233124
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2017
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ROXONIN TAPE 50 mg Cutaneous Patch
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        LOXOPROFEN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Topical
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Cutaneous patch
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        7
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Pouch
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        34.50
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="LEAD CHEMICAL CO., LTD." />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            LEAD CHEMICAL CO., LTD.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>ROXONIN TAPE belongs to a group of medicines called Non-Steroidal Anti- Inflammatory drugs (NSAIDs).</p><p>ROXONIN TAPE has excellent analgesic, anti-inflammatory properties, particularly in acute inflammations, chronic inflammations and pain.</p><p>After being absorbed transdermally, loxoprofen sodium hydrate is biotransformed into an active metabolite trans-OH form (SRS coordination) to exert its excellent anti-inflammatory and analgesic effects</p><p>ROXONIN TAPE is used as anti-inflammation and analgesia in the following diseases and symptoms:</p><p>Osteoarthritis, myalgia, posttraumatic swelling and pain.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take ROXONIN TAPE, </strong>if you have;</p><p>A history of hypersensitivity to any ingredients of ROXONIN TAPE.</p><p>A history of aspirin-induced asthma (induction of asthmatic attack with nonsteroidal anti- inflammatory-analgesics, etc.) (May induce an aspirin-induced asthmatic attack).</p><p>During third trimester of pregnancy</p><p><strong>Take special care with ROXONIN TAPE</strong></p><p><strong>Before taking ROXONIN TAPE, </strong>tell your doctor if you</p><p>Have bronchial asthma (as the disease state may be exacerbated.)</p><p><strong>Important Precautions</strong></p><p>It is important to note that treatment with anti-inflammatory-analgesic agents is a symptomatic treatment, not a causal treatment.</p><p>For treatment of skin inflammation caused by infectious disease, ROXONIN TAPE may cause a risk of masking the signs and symptoms of the infectious disease, therefore, the appropriate antibacterial and/or antifungal drugs must be administered in combination with ROXONIN TAPE to the affected part of the skin, under careful observation and caution.</p><p>Therapies other than drug treatment must also be considered in using ROXONIN TAPE in the management of chronic diseases (osteoarthritis and others).</p><p><strong>Pregnancy and breast-feeding</strong></p><p><strong>Pregnancy</strong></p><p>You should ask your doctor if you are or are possibly pregnant before taking this drug. ROXONIN TAPE should be administered only when the anticipated therapeutic benefits are considered to outweigh any</p><p>potential risk. [The safety of ROXONIN TAPE in these populations has not been established.]</p><p>You should not take this medicine if you are in the late stages of pregnancy.</p><p><strong>Breast-feeding</strong></p><p>Ask your doctor or pharmacist for advice before taking any medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Dosage, Methods and routes of administration</strong></p><p>Always take ROXONIN TAPE exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p>ROXONIN TAPE should be applied once daily to the affected area.</p><p>Site of application:</p><p>Do not apply ROXONIN TAPE onto area of damaged or non-intact skin or mucosal membrane.</p><p>Do not apply ROXONIN TAPE onto area of eczema and rash.</p><p><strong>Precautions for Handling</strong></p><p>After removing the patch from the pouch for use, be sure to close it securely by gently pressing both sides of its zip-lock portion against each other.</p><p><strong>Use in the Elderly</strong></p><p>A significant greater incidence of adverse reactions in the elderly patients age &ge; 65</p><p>were observed in the post marketing surveillance of ROXONIN TAPE (50mg/100mg).</p><p>Since the major adverse reactions included dermal symptoms at the application area, ROXONIN TAPE should be used with careful monitoring of dermal condition of application area, in the elderly patients age _ 65.</p><p><strong>Use during Pregnancy, Delivery or Lactation</strong></p><p>ROXONIN TAPE should be administered to women who are or are possibly pregnant only when the anticipated therapeutic benefits are considered to outweigh any potential risk. [The safety of ROXONIN TAPE in these populations has not been established.]</p><p>It has been reported that constriction of the fetal ductus arteriosus is observed when woman in the late stage of pregnancy received other nonsteroidal anti-inflammatory-analgesic drugs for external use.</p><p><strong>Pediatric Use</strong></p><p>The safety of ROXONIN TAPE in low birth weight infants, newborn infants, Infants and toddlers, children and adolescents has not been established (because there has been little experience of its use in pediatric patients).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, ROXONIN TAPE can cause side effects, although not everybody gets them. If you are worried about side effects, ask your doctor. It is important that you know what can happen, so that you can take action if ROXONIN TAPE does have a side effect</p><p>If use of ROXONIN TAPE results in development of any symptom listed below, stop using the patch preparation or take other appropriate remedy depending on the severity of the symptom.</p><table border="1" cellspacing="0" cellpadding="0" style="width:802px"><tbody><tr><td><p>Incidence</p></td><td><p>Adverse Reaction</p></td><td><p>0.5% to &lt; 3%</p></td><td><p>&lt; 0.5%</p></td><td><p>Incidence unknown*</p></td></tr><tr><td colspan="2"><p>Hypersensitivity</p></td><td><p>Pruritus, erythema, contact dermatitis, rash</p></td><td><p>Haemorrhage subcutaneous, skin irritation, pigment precipitation</p></td><td><p>Blister, swelling</p></td></tr><tr><td colspan="2"><p>Gastrointestinal</p></td><td><p>&nbsp;</p></td><td><p>Stomach discomfort, upper abdominal pain, diarrhea, loose stools</p></td><td><p>&nbsp;</p></td></tr><tr><td colspan="2"><p>Hepatic</p></td><td><p>&nbsp;</p></td><td><p>Increased AST (GOT), increased ALT (GPT), increased y-GTP</p></td><td><p>&nbsp;</p></td></tr><tr><td colspan="2"><p>Other</p></td><td><p>&nbsp;</p></td><td><p>Edema</p></td><td><p>&nbsp;</p></td></tr></tbody></table><p>*The incidence of adverse reactions is unknown as these adverse reactions are those which have been reported spontaneously.</p><p>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.</p><p>ROXONIN TAPE must be stored in light-proof tightly-sealed container below 25 &deg;C</p><p>ROXONIN TAPE must be used before the expiration date indicated on the package or label.</p><p>Medicinal should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Active Ingredient</p><p>ROXONIN TAPE50mg</p><p>Loxoprofen sodium hydrate 56.7mg (50mg as anhydride) in a sheet (1g of ointment)</p><p>ROXONIN TAPE&reg;TAPE100mg</p><p>Loxoprofen sodium hydrate 113.4mg (100mg as anhydride) in a sheet (2g of ointment)</p><p>Inactive Ingredients</p><p>Styrene-isoprene-styrene block copolymer, polyisobutylene, hydrated silicon dioxide, hydrogenated rosin glycerol ester, dibutyl hydroxytoluene, l-menthol, liquid paraffin and Phosphoric acid.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                ROXONIN TAPE is packaged in pouches, each containing seven (7) patches, for supply in a package size: 1 pouch (7 patches) per package
 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Manufactured by:</p><p>Lead Chemical CO. Ltd, Tokyo, Japan</p><p>For SAJA pharmaceutical,</p><p>Jeddah, KSA.</p><p>To rebort any side effect</p><p><strong>&bull; Saudi Arabia</strong></p><p>- The National Pharmacovigilance Centre (NPC):<br />- SFDA Call Center: 19999<br />- E-mail: npc.drug@sfda.gov.sa<br />- Website: hpps://ade.sfda.gov.sa</p><p><strong>&bull; Other GCC states /other countries</strong><br />-Please contact the relevant competent authority.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                October /2022
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">ينتمي روكسونين تيب إلى مجموعة من الأدوية تُسمى مضادات الالتهاب غير الستيرويدية.</p><p dir="RTL">يتسم روكسونين تيب بخصائص ممتازة مسكنة ومضادة للالتهاب لا سيما في حالات الالتهاب الحاد والمزمن والألم.</p><p dir="RTL">بعد امتصاص هيدرات صوديوم اللوكسوبرفين عبر الجلد، يتحول حيوياً إلى المستقلب الناشط &quot;trans-OH form&quot; (تناسق في صيغة SRS)</p><p dir="RTL">ليولد تأثيره الممتاز المسكن والمضاد للالتهاب.</p><p dir="RTL">يُستخدم روكسونين تيب كمضاد للالتهاب ومسكن في حالات الإصابة بالأمراض والأعراض التَّالية:</p><p dir="RTL">التهاب المفاصل والآلام بالعضلات والتَّورم بعد الإصابة والألم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تستخدم روكسونين تيب في الحالات التَّالية:</strong></p><p dir="RTL">إذا كان لديك تاريخ مرضي من الإصابة بفرط الحساسية تجاه أي من مكونات روكسونين تيب.</p><p dir="RTL">إذا كان لديك تاريخ مرضي من الإصابة بالربو محفز بتناوُل الأسبرين )تحفيز نوبات الربو بمضادات الالتهاب غير الستيرويدية المسكنة، وما إلى ذلك) (فقد يحفز نوبة الربو المحفز بتناوُل الأسبرين).</p><p dir="RTL">خلال الثلث الثالث من الحمل&nbsp;</p><p dir="RTL"><strong>توخ حذرًا خاصا مع روكسونين تيب</strong></p><p dir="RTL">قبل استخدام روكسونين تيب، أخبر طبيبك إذا كنت تعاني ربوًا شعبيا (إذ قد يتفاقم المرض(</p><p dir="RTL"><strong>احتياطات هامة</strong></p><p dir="RTL">من المهم ملاحظة أن العلاج بالمسكنات المضادة للالتهاب هو علاج لأعراض المرض وليس لأسبابه.</p><p dir="RTL">لعلاج التهاب الجلد الناتج عن مرض معدٍ، قد يتسبب روكسونين تيب في إخفاء علامات وأعراض المرض المعدي، من ثم يجب استخدام المضادات البكتيرية و/أو الفطرية اللازمة بمصاحبة روكسونين</p><p dir="RTL">تيب على الجزء المصاب من الجلد مع إخضاع المريض للملاحظة وتوخي الحذر والدقة.</p><p dir="RTL">يجب أيضًا الأخذ بالاعتبار تلقي علاجات أخرى بخلاف العلاج بالعقاقير عند استخدام روكسونين تيب في السيطرة على الأمراض المزمنة (التهاب المفاصل وأمراض أخرى).</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL">الحمل</p><p dir="RTL">يجب عليكِ استشارة طبيبكِ قبل استخدام هذا الدَّواء إذا كنتِ حاملًا أو يحتمل أن تكوني كذلك. يجب عدم استخدام روكسونين تيب إلا إذا كانت الفوائد المتوقعة من استخدامه تفوق المخاطر المحتملة له. لم يثبت أمان روكسونين تيب في علاج هذه الشريحة من المرضي)</p><p dir="RTL">يجب عليكِ الامتناع عن استخدام هذا الدَّواء إذا كنت في المراحل الأخيرة من الحمل.</p><p dir="RTL">الرَّضاعة الطبيعية</p><p dir="RTL">استشيري طبيبَك أو الصيدلي الخاص بكِ قبل استخدام أي دواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>الجرعة وأسلوب وطريقة الاستخدام</strong></p><p dir="RTL">استخدم دائمًا روكسونين تيب كما أخبرك طبيبك بالضبط. يجب عليك مراجعة الطبيب أو الصيدلي الخاص بك إذا لم تكن متأكدًا من كيفية الاستخدام.</p><p dir="RTL">يجب وضع روكسونين تيب على المنطقة المصابة مرة يومي</p><p dir="RTL"><strong>موضع الاستعمال:</strong></p><p dir="RTL">لا تضع روكسونين تيب على الجلد التَّالف أو غير السليم أو الأغشية المخاطية.</p><p dir="RTL">لا تضع روكسونين تيب على مواضع الإصابة بالأكزيما أو الطفح الجلدي.</p><p dir="RTL"><strong>احتياطات خاصة بالاستعمال</strong></p><p dir="RTL">بعد إزالة الشريط الاصق من الكيس للاستخدام، تأكد من إحكام إغلاق الكيس بضغط جانبيّ سحاب غلق الكيس على أحدهما الآخر برفق.</p><p dir="RTL">الاستخدام في كبار السن</p><p dir="RTL">تم رصد حدوث التفاعلات العكسية بدرجة أكبر على نحو ملحوظ في المرضى من كبار السن الذين تزيد أعمارهم على ٦٥ عامًا في مرحلة مراقبة ما بعد تسويق روكسونين تيب ( ٥۰ ملج/ ۱۰۰ ملج). يجب</p><p dir="RTL">استخدام روكسونين تيب مع مراقبة حالة الجلد بعناية في موضع الاستعمال في المرضى من كبار السن الذين تزيد أعمارهم عن ٦٥ عامًا؛ إذ شملت التفاعلات العكسية الهامة لاستخدامه أعراضًا جلدية في موضع الاستعمال.</p><p dir="RTL"><strong>الاستعمال أثناء الحمل أو الولادة أو الإرضاع</strong></p><p dir="RTL">يجب عدم استخدام روكسونين تيب في السيدات الحوامل أو اللائي قد يكن كذلك إلا في الحالات التي يتوقع فيها أن تفوق الفوائد العلاجية لروكسونين تيب أي مخاطر محتملة لاستخدامه). [لم يثبت أمان روكسونين تيب في علاج هذه الشريحة من المرضى)</p><p dir="RTL">تم الإبلاغ عن رصد انحصار القناة الشريانية المغذية للجنين عند تلقي السيدات في المرحلة الأخيرة من الحمل مسكنات أخرى من مضادات الالتهاب غير الستيرويدية المخصصة للاستعمال الخارجي.</p><p dir="RTL"><strong>الاستخدام في الأطفال</strong></p><p dir="RTL">لم يثبت أمان استخدام روكسونين تيب في الرضع الذين تقل أوزانهم عن الوزن الطبيعي عند الولادة وفي حديثي الولادة والرضع والأطفال الصغار والأطفال الأكبر سناً والمراهقين (نظرًا لوجود خبرات قليلة عن استخدامه في المرضى من الأطفال(.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثله مثل كافة الأدوية، قد يُسبب روكسونين تيب آثارًا جانبية، على الرغم من عدم حدوثها لدى الجميع. إذا شعرت بالقلق حيال الآثار الجانبية، استشر طبيبك. من المهم أن تعي ما قد يحدث لك؛</p><p dir="RTL">لتتخذ الإجراءات اللازمة إذا تسبب روكسونين تيب في آثار جانبية.</p><p dir="RTL">إذا تسبب روكسونين تيب في ظهور أي من الأعراض المدرجة أدناه، توقف عن استخدامه أو خذ علاجًا آخر مناسبًا بناءً على شدة الأعراض.</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:773px"><tbody><tr><td><p dir="RTL">التفاعلات العكسية</p></td><td><p dir="RTL">نسبة حدوث</p></td><td><p dir="RTL">0.5% إلى &lt;0.3%</p></td><td><p dir="RTL">&lt;0.5 %</p></td><td><p dir="RTL">نسبة الحدوث غير معروفة *</p></td></tr><tr><td colspan="2"><p dir="RTL">فرط الحساسية</p></td><td><p dir="RTL">حكة احمرار، التهاب جلد التماسي ، طفح جلدي</p></td><td><p dir="RTL">نزيف تحت الجلد، تهيج الجلد، الترسب الصبغي</p></td><td><p dir="RTL">بثور ، تورم</p></td></tr><tr><td colspan="2"><p dir="RTL">شعور بالضيق في المعدة والأمعاء</p></td><td><p dir="RTL">&nbsp;</p></td><td><p dir="RTL">ألم بالجزء العلوي من البطن، إسهال، براز رخو ....</p></td><td><p dir="RTL">&nbsp;</p></td></tr><tr><td colspan="2"><p dir="RTL">زيادة</p></td><td><p dir="RTL">&nbsp;</p></td><td><p dir="RTL">في مستوى إنزيمات ناقلة الأمين الأسبارتية، وإنزيمات ناقلة الأمين الألاتينية، وناقلة البيتيد جاما جلوتاميل واي في الكبد.</p></td><td><p dir="RTL">&nbsp;</p></td></tr><tr><td colspan="2"><p dir="RTL">أثار جانبية</p></td><td><p dir="RTL">&nbsp;</p></td><td><p dir="RTL">وذمة.</p></td><td><p dir="RTL">&nbsp;</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL">*نسب حدوث التفاعلات العكسية غير معروفة؛ إذ تم الإبلاغ عنها بشكل تلقائي.</p><p dir="RTL">إذا أصبح أيٌّ من الآثار الجانبية خطيرًا، أو إذا لاحظت أية آثار جانبية غير المدرجة في هذه النَّشرة، فيُرجى</p><p dir="RTL">إبلاغ الطبيب أو الصيدلي الخاص بك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يُحفظ بعيدًا عن مُتناوَل ورؤية الأطفال.</p><p dir="RTL">يجب تخزين روكسونين تيب في حاوية واقية من الضوء مغلقة بإحكام في درجة حرارة أقل من ۲٥ درجة مئوية.</p><p dir="RTL">يجب استخدام روكسونين تيب قبل تاريخ انتهاء الصلاحية المدون على العبوة أو المُلصق.</p><p dir="RTL">يجب عدم التَّخلص من هذا المنتج الدَّوائي عن طريق مياه الصرف أو مع المخلفات المنزلية. اسأل الصيدلي الخاص بك عن كيفية التَّخلص من الأدوية التي لم تعد بحاجة إليها. ستُساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعّالة</p><p dir="RTL">روكسونين تيب ٥۰ ملج.</p><p dir="RTL">هيدرات صوديوم اللوكسوبروفين ٥٦٫۷ ملج ( ٥۰ ملج في هيئة لا مائي) في ورقة (تحتوي على ۱ ملج من المرهم).</p><p dir="RTL">روكسونين تيب ۱۰۰ ملج.</p><p dir="RTL">هيدرات صوديوم اللوكسوبروفين ۱۱۳٫٤ ملج ) ۱۰۰ ملج في هيئة لا مائي ( في ورقة )تحتوي على ۲ ملج من المرهم(.</p><p dir="RTL">المواد غير الفعَّالة</p><p dir="RTL">بوليمرات ستايرين إيزوبرين المشتركة الحاصرة، بولي أيزو بوتيلين، ثنائي أكسيد السليكون المائي، إستر جليسرول الروزين المهدرج، ثنائي بوتيل هيدروكسي تولوين، إل-منثول، البارافين السائل، وحمض الفوسفوريك.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يُعبأ روكسونين تيب في أكياس، يحتوي كل منها على ۷ شرائط لاصقة، ويتوفر بأحجام العبوات التَّالية: عبوة من كيس واحد )يحتوي على ۷ شرائط لاصقة(</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">جهة التَّصنيع:</p><p dir="RTL">شركة ليد كيميكال المحدودة، طوكيو، اليابان،</p><p dir="RTL">لصالح شركة ساجا للأدوية</p><p dir="RTL">جدة، المملكة العربية السعودية</p><p dir="RTL">للإبلاغ عن أية آثار جانبية<br /><strong>&bull; المملكة العربية السعودية</strong><br />- المركز الوطني للتيقظ والسامة الدوائية<br />- مركز اتصالات الهيئة العامة للغذاء والدواء السعودية : 19999<br />&nbsp;npc.drug@sfda.gov.sa :- البريد الإلكتروني<br />&nbsp;https://ade.sfda.gov.sa :- الموقع الإلكتروني<br /><strong>&bull; دول الخليج الأخرى/ الدول الأخرى</strong><br />- الرجاء الاتصال بالمؤسسات و الهيئات الوطنية في كل دولة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            اكتوبر/ 2022
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Roxonin Tape 50 mg
Roxonin Tape 100 mg
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Roxonin Tape 50 mg
Loxoprofen sodium hydrate (JP) 56.7mg (50mg as anhydride) in a sheet (1g of ointment)
Roxonin Tape 100 mg
Loxoprofen sodium hydrate (JP) 113.4mg (100mg as anhydride) in a sheet (2g of ointment)
Inactive Ingredients
Styrene-isoprene-styrene block copolymer, polyisobutylene, hydrated silicon dioxide, hydrogenated
rosin glycerol ester, dibutyl hydroxytoluene, l-menthol, and two other components
For a full list of excipients, see section 6.1
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Patch preparation comprising ointment, spread over a support with the surface of the ointment
covered by a liner.PHYSICOCHEMICAL PROPERTIES OF THE ACTIVE INGREDIENTS
Generic name: Loxoprofen Sodium Hydrate
Chemical name: Monosodium 2-{4-[(2-oxocyclopentyl)methyl] phenyl}propanoate dihydrate
Molecular formula: C15H17NaO3･2H2O
Molecular weight: 304.31
Description: Loxoprofen sodium hydrate occurs as a
white to off-white crystal or crystalline powder. It is very soluble in water and in methanol, freely soluble in
ethanol (95) and practically insoluble in diethyl ether.
A solution of loxoprofen sodium (1 → 20) shows no optical rotation
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ROXONIN TAPE is indicated for anti-inflammation and analgesia in the following diseases and<br />symptoms: Osteoarthritis, myalgia, post traumatic swelling and pain<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology:<br />ROXONIN TAPE should be applied once daily to the affected area.<br />Use in the Elderly<br />Significant greater incidence of adverse reactions in the elderly patients age &ge; 65 (3.7%,<br />65/1,738 patients) compared to age &lt; 65, (1.7%,22/1,300 patients) were observed in the post<br />marketing surveillance of and ROXONIN TAPE (50mg/100mg). Since the major adverse<br />reactions included dermal symptoms at the application area, ROXONIN TAPE should be used<br />with careful monitoring of dermal condition of application area, in the elderly patients age &ge; 65.<br />Pediatric Use<br />The safety of ROXONIN TAPE in low birth weight infants, newborn infants, Infants and toddlers,<br />children and adolescents has not been established (because there has been little experience of its<br />use in pediatric patients).<br />Precautions Concerning Use<br />Site of application:<br />(1) Do not apply ROXONIN TAPE onto area of damaged or non-intact skin or mucosal membrane.<br />(2) Do not apply ROXONIN TAPE onto area of eczema and rash<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                ROXONIN® TAPE is contraindicated in the following patients.
1. Patients with a history of hypersensitivity to any ingredients of ROXONIN TAPE.
2. Patients with or with a history of aspirin-induced asthma (induction of asthmatic attack
with non steroidal anti-inflammatory-analgesics, etc.)
 3. During third trimester of pregnancy.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>1) Careful Administration (ROXONIN TAPE should be administered with<br />caution in the following patients.)<br />Patients with bronchial asthma (as the disease state may be exacerbated.)<br />2) Important Precautions<br />(1) It is important to note that treatment with anti-inflammatory-analgesic agents is a<br />symptomatic treatment, not a causal treatment.<br />(2) For treatment of skin inflammation caused by infectious disease, ROXONIN TAPE may cause<br />a risk of masking the signs and Symptoms of the infectious disease, therefore, the appropriate<br />antibacterial and/or antifungal drugs must be administered in combination with ROXONIN TAPE<br />to the affected part of the skin, under careful observation and caution.<br />(3) Therapies other than drug treatment must also be considered in using ROXONIN TAPE in the<br />management of chronic diseases (osteoarthritis and others). The patient&rsquo;s clinical condition<br />should be closely monitored with caution against the development of adverse reactions<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No drug-drug interaction occurs<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy category C<br />ROXONIN TAPE should be administered to women who are or are possibly pregnant only when the<br />anticipated therapeutic benefits are considered to outweigh any potential risk. [The safety of<br />ROXONIN TAPE in these populations has not been established.]<br />It has been reported that constriction of the fetal ductus arteriosus is observed when woman in<br />the late stage of pregnancy received other non steroidal anti-inflammatory-analgesic drugs for<br />external use.<br />Renal impairment and decreased urine output in foetuses as well as accompanying oligohydramnios have been reported following use of cyclooxygenase inhibitors (oral dosage form or suppository) in pregnant women.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There has been no clinical trial conducted for evaluating frequency of adverse event of ROXONIN<br />TAPE to date.<br />However, adverse reactions with use of ROXONIN TAPE 100mg were reported in 91 (8.5%) of<br />1,075 patients for safety evaluation before approval (based on their subjective/objective<br />symptoms and clinical laboratory data). The major adverse reactions included dermal<br />symptoms such as itching (2.1%), erythema (1.5%) and contact dermatitis (1.4%),<br />gastrointestinal symptoms such as stomach discomfort (0.6%), and abnormal clinical laboratory<br />values such as increased ALT (0.6%) and increased AST (0.5%). Adverse reactions with use of<br />ROXONIN TAPE 100mg and ROXONIN TAPE (50mg/100mg) were reported in 87 (2.9%) of<br />3,038 patients included in the post marketing surveillance. The major adverse reactions<br />included dermal symptoms such as contact dermatitis (1.4%), pruritus (0.5%) and erythema<br />(0.4%). [At the end of the re examination period.]<br />If use of ROXONIN TAPE results in development of any symptom listed below, stop using the<br />patch preparation or take other appropriate remedy depending on the severity of the symptom</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>0.5% to &lt; 3%</p></td><td style="vertical-align:top"><p>&lt; 0.5%</p></td><td style="vertical-align:top"><p>Incidence unknown Note</p></td></tr><tr><td style="vertical-align:top"><p>Hypersensitivity</p></td><td style="vertical-align:top"><p>Pruritus,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; erythema, contact dermatitis, rash</p></td><td style="vertical-align:top"><p>Haemorrhage subcutaneous,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin irritation,</p></td><td style="vertical-align:top"><p>Blister, swelling</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Stomach discomfort,&nbsp;&nbsp; upper abdominal&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pain,</p><p>diarrhea,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; loose stools</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Hepatic</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Increased AST(GOT),</p><p>increased</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Other</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Edema</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p>[Cumulative results from use of ROXONIN TAPE 100mg and ROXONIN TAPE (50mg/100mg)]</p><p>&nbsp;</p><p>Note: The incidence of adverse reactions is unknown as these adverse reactions are those which have been reported spontaneously.</p><p><strong>To report any side effect(s):</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong>Saudi Arabia :</strong>&nbsp; <!--[if gte vml 1]><o:wrapblock><v:shapetype
  id="_x0000_t202" coordsize="21600,21600" o:spt="202" path="m,l,21600r21600,l21600,xe">
  <v:stroke joinstyle="miter"/>
  <v:path gradientshapeok="t" o:connecttype="rect"/>
 </v:shapetype><v:shape id="_x0000_s1027" type="#_x0000_t202" style='position:absolute;
  left:0;text-align:left;margin-left:84.4pt;margin-top:30.9pt;width:426.7pt;
  height:85.35pt;text-indent:0;z-index:-15724544;mso-wrap-distance-left:0;
  mso-wrap-distance-right:0;mso-position-horizontal-relative:page' filled="f"
  strokeweight=".48pt">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:.65pt;margin-right:204.5pt;
     margin-bottom:0in;margin-left:5.35pt;margin-bottom:.0001pt;text-indent:
     -.05pt'><span style='font-size:12.0pt;mso-bidi-font-size:11.0pt;
     font-family:"Times New Roman",serif;mso-bidi-font-family:Tahoma'>−
     National Pharmacovigilance Center (NPC)<span style='letter-spacing:-2.85pt'>
     </span>O Fax: +966-11-205-7662<o:p></o:p></span></p>
     <p class=MsoNormal style='margin-top:.05pt;margin-right:0in;margin-bottom:
     0in;margin-left:5.35pt;margin-bottom:.0001pt'><span style='font-size:12.0pt;
     mso-bidi-font-size:11.0pt;font-family:"Times New Roman",serif;mso-hansi-font-family:
     Tahoma;mso-bidi-font-family:Tahoma'>O<span style='letter-spacing:-.05pt'> </span>SFDA<span
     style='letter-spacing:-.1pt'> </span>Call Center:<span style='letter-spacing:
     -.05pt'> </span>19999<o:p></o:p></span></p>
     <p class=MsoNormal style='margin-top:.05pt;margin-right:0in;margin-bottom:
     0in;margin-left:5.35pt;margin-bottom:.0001pt'><span style='font-size:12.0pt;
     mso-bidi-font-size:11.0pt;font-family:"Times New Roman",serif;mso-hansi-font-family:
     Tahoma;mso-bidi-font-family:Tahoma'>O<span style='letter-spacing:-.05pt'> </span>E-mail:
     </span><a href="mailto:npc.drug@sfda.gov.sa"><span style='font-size:12.0pt;
     mso-bidi-font-size:11.0pt;font-family:"Times New Roman",serif;mso-hansi-font-family:
     Tahoma;mso-bidi-font-family:Tahoma;color:windowtext;text-decoration:none;
     text-underline:none'>npc.drug@sfda.gov.sa</span></a><span
     style='font-size:12.0pt;mso-bidi-font-size:11.0pt;font-family:"Times New Roman",serif;
     mso-hansi-font-family:Tahoma;mso-bidi-font-family:Tahoma'><o:p></o:p></span></p>
     <p class=MsoNormal style='margin-top:.05pt;margin-right:0in;margin-bottom:
     0in;margin-left:5.35pt;margin-bottom:.0001pt'><span style='font-size:12.0pt;
     mso-bidi-font-size:11.0pt;font-family:"Times New Roman",serif;mso-hansi-font-family:
     Tahoma;mso-bidi-font-family:Tahoma'>O<span style='letter-spacing:-.05pt'> </span>Website:
     https://ade.sfda.gov.sa<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
  <w:wrap type="topAndBottom" anchorx="page"/>
 </v:shape><![endif]--></p><table cellpadding="0" cellspacing="0"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td><img width="574" height="120" alt="Text Box: − National Pharmacovigilance Center (NPC) O Fax: +966-11-205-7662
O SFDA Call Center: 19999
O E-mail: npc.drug@sfda.gov.sa
O Website: https://ade.sfda.gov.sa
" src="file:///C:/Users/AMR~1.MAK/AppData/Local/Temp/msohtmlclip1/01/clip_image001.gif" /></td></tr></tbody></table><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other GCC States:</strong></p><p><!--[if mso & !supportInlineShapes & supportFields]><span
style='font-size:10.0pt;mso-bidi-font-size:9.5pt;font-family:"Times New Roman",serif;
mso-hansi-font-family:Tahoma;mso-bidi-font-family:Tahoma'><span
style='mso-element:field-begin;mso-field-lock:yes'></span><span
style='mso-spacerun:yes'> </span>SHAPE <span
style='mso-spacerun:yes'> </span>\* MERGEFORMAT <span style='mso-element:field-separator'></span></span><![endif]--><!--[if gte vml 1]><v:shape
 id="_x0000_s1026" type="#_x0000_t202" style='width:440.15pt;height:16.35pt;
 mso-left-percent:-10001;mso-top-percent:-10001;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:char;mso-position-vertical:absolute;
 mso-position-vertical-relative:line;mso-left-percent:-10001;mso-top-percent:-10001'
 filled="f" strokeweight=".48pt">
 <v:textbox inset="0,0,0,0">
  <![if !mso]>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=MsoNormal style='margin-top:.8pt;margin-right:0in;margin-bottom:
    0in;margin-left:32.35pt;margin-bottom:.0001pt'><span style='font-size:12.0pt;
    mso-bidi-font-size:11.0pt;font-family:"Times New Roman",serif;mso-hansi-font-family:
    Tahoma;mso-bidi-font-family:Tahoma'>Please<span style='letter-spacing:-.15pt'>
    </span>contact<span style='letter-spacing:-.1pt'> </span>the relevant<span
    style='letter-spacing:-.1pt'> </span>competent<span style='letter-spacing:
    -.05pt'> </span>authority.<o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
 <w:wrap type="none"/>
 <w:anchorlock/>
</v:shape><![endif]--><img width="593" height="28" alt="Text Box: Please contact the relevant competent authority." src="file:///C:/Users/AMR~1.MAK/AppData/Local/Temp/msohtmlclip1/01/clip_image002.gif" /><!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><![endif]--><!--[if mso & !supportInlineShapes & supportFields]><span
style='font-size:10.0pt;mso-bidi-font-size:9.5pt;font-family:"Times New Roman",serif;
mso-hansi-font-family:Tahoma;mso-bidi-font-family:Tahoma'><v:shape id="_x0000_i1025"
 type="#_x0000_t75" style='width:440.15pt;height:16.35pt'>
 <v:imagedata croptop="-65520f" cropbottom="65520f"/>
</v:shape><span style='mso-element:field-end'></span></span><![endif]--></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable<br />&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>CLINICAL STUDIES<br />The results from clinical studies of the product, including double blind controlled comparative<br />trials against ROXONIN TAPE 100mg conducted in Japan were as summarized below</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Diagnosis</p></td><td style="vertical-align:top"><p>Efficacy rate (Number of responder/total)</p></td></tr><tr><td style="vertical-align:top"><p>Osteoarthritis</p></td><td style="vertical-align:top"><p>75.5%</p></td></tr><tr><td style="vertical-align:top"><p>Myalgia</p></td><td style="vertical-align:top"><p>80.7%</p></td></tr><tr><td style="vertical-align:top"><p>Post-traumatic swelling and pain</p></td><td style="vertical-align:top"><p>98.1%</p></td></tr></tbody></table><p>Anti-inflammatory effect<br />ROXONIN TAPE 100mg has been demonstrated significant an anti-inflammatory effect on both<br />acute inflammations such as carrageenin-induced edema (rat) and chronic inflammations such<br />as adjuvant arthritis (rat).<br />Analgesic effect)<br />ROXONIN TAPE 100mg has been demonstrated to show the analgesic effect in the RandollSelitto test (inflamed paw pressuring method: rat), and in the chronic adjuvant arthritis pain test<br />(rat)<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption and Metabolism<br />Clinical studies to evaluate the bioequivalence between ROXONIN TAPE (50mg/100mg) and<br />ROXONIN TAPE 100mg in healthy male subjects by applying the patch preparation on the back<br />of each subject conformed that the concentration of loxoprofen in the horny layer of the skin in<br />the subjects treated with ROXONIN TAPE was equal to that in the subjects treated with<br />ROXONIN TAPE 100mg.<br />After being absorbed transdermally, loxoprofen sodium hydrate is biotransformed into an active<br />metabolite trans-OH form (SRS coordination) to exert its excellent anti-inflammatory and<br />analgesic effects in acute inflammations, chronic inflammations and pain<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No safety information<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Active Ingredient<br />Roxonin Tape 50 mg<br />Loxoprofen sodium hydrate (JP) 56.7mg (50mg as anhydride) in a sheet (1g of ointment)<br />Roxonin Tape 100 mg<br />Loxoprofen sodium hydrate (JP) 113.4mg (100mg as anhydride) in a sheet (2g of ointment)<br />Inactive Ingredients<br />Styrene-isoprene-styrene block copolymer, polyisobutylene, hydrated silicon dioxide, hydrogenated<br />rosin glycerol ester, dibutyl hydroxytoluene, l-menthol, liquid paraffin and Phosphoric acid<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Don&rsquo;t Store above 25&deg;C, store in a light resistant and airtight container.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>How supplied<br />ROXONIN TAPE is packaged in pouches, each containing seven (7) patches, for supply in a<br />package size: 1 pouch (7 patches) per package</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="2" style="vertical-align:top"><p>Brand name</p></td><td style="vertical-align:top"><p>Patch Size</p></td><td style="vertical-align:top"><p>color</p></td><td style="vertical-align:top"><p>Smell</p></td></tr><tr><td style="vertical-align:top"><p>ROXONIN</p></td><td style="vertical-align:top"><p>TAPE</p></td><td style="vertical-align:top"><p>7cm&times;10cm</p></td><td style="vertical-align:top"><p>The&nbsp;&nbsp;&nbsp;&nbsp; ointment</p></td><td style="vertical-align:top"><p>The&nbsp;&nbsp;&nbsp;&nbsp; ointment</p></td></tr><tr><td style="vertical-align:top"><p>TAPE50mg</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>surface is light</p></td><td style="vertical-align:top"><p>has a specific</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>brown&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to</p></td><td style="vertical-align:top"><p>characteristic</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td rowspan="2" style="vertical-align:top"><p>brown in color</p></td><td rowspan="2" style="vertical-align:top"><p>fragrance</p></td></tr><tr><td style="vertical-align:top"><p>ROXONIN</p></td><td style="vertical-align:top"><p>TAPE</p></td><td style="vertical-align:top"><p>10cm&times;14cm</p></td></tr><tr><td style="vertical-align:top"><p>TAPE100mg</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Manufactured by:
Lead Chemical CO. Ltd, Tokyo, Japan
For SAJA pharmaceutical,
Jeddah, KSA
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                October 2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>